Western Pacific Wealth Management, LP Corvus Pharmaceuticals, Inc. Transaction History
Western Pacific Wealth Management, LP
- $95.6 Million
- Q3 2025
A detailed history of Western Pacific Wealth Management, LP transactions in Corvus Pharmaceuticals, Inc. stock. As of the latest transaction made, Western Pacific Wealth Management, LP holds 2,000 shares of CRVS stock, worth $17,540. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,000
Previous 2,000
-0.0%
Holding current value
$17,540
Previous $8,000
75.0%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding CRVS
# of Institutions
111Shares Held
38.3MCall Options Held
198KPut Options Held
167K-
Orbimed Advisors LLC San Diego, CA7.17MShares$62.8 Million1.75% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct6.45MShares$56.6 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$30.4 Million0.0% of portfolio
-
Adams Street Partners LLC Chicago, IL3.28MShares$28.7 Million16.52% of portfolio
-
Rtw Investments, LP New York, NY2.68MShares$23.5 Million0.26% of portfolio
About Corvus Pharmaceuticals, Inc.
- Ticker CRVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,553,500
- Market Cap $408M
- Description
- Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...